Carterra Revenue and Competitors

Location

$38.1M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Carterra's estimated annual revenue is currently $15.8M per year.(i)
  • Carterra received $10.0M in venture funding in January 2018.
  • Carterra's estimated revenue per employee is $155,000
  • Carterra's total funding is $38.1M.

Employee Data

  • Carterra has 102 Employees.(i)
  • Carterra grew their employee count by -3% last year.

Carterra's People

NameTitleEmail/Phone
1
VP Research & DevelopmentReveal Email/Phone
2
ControllerReveal Email/Phone
3
VP, Marketing and ProductReveal Email/Phone
4
Chief Production OfficerReveal Email/Phone
5
Director ScienceReveal Email/Phone
6
Chief Commercial OfficerReveal Email/Phone
7
Associate Director Systems EngineeringReveal Email/Phone
8
Director SalesReveal Email/Phone
9
Director New Product DevelopmentReveal Email/Phone
10
Director ResearchReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M5-17%N/AN/A
#2
$1.4M9-10%N/AN/A
#3
$5.9M3841%N/AN/A
#4
$1.1M7-53%N/AN/A
#5
$1.6M1011%N/AN/A
#6
$21.2M13710%N/AN/A
#7
$1.6M33-48%$17.8MN/A
#8
$1.9M120%N/AN/A
#9
$3.7M249%N/AN/A
#10
$0.9M60%N/AN/A
Add Company

What Is Carterra?

Carterra, formerly Wasatch Microfluidics, develops high throughput surface plasmon resonance array-based platforms for biomolecular interaction analysis. Our new name is based on two core concepts: Cartography (mapping) and terra (worlds), literally meaning mapping worlds. This represents the Company's high-speed, high-resolution label-free biosensor technologies, which are being used by leading pharmaceutical and biotechnology companies to thoroughly explore their large monoclonal antibody (mAb) libraries to discover novel biotherapeutic candidates.

keywords:Biotechnology,Healthcare

$38.1M

Total Funding

102

Number of Employees

$15.8M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Carterra News

2022-04-17 - Genovac Acquires the Carterra LSA® Instrument to Enable State-of ...

Carterra launched the LSA antibody discovery and characterization platform in 2018 utilizing high-throughput Surface Plasmon Resonance (HT-SPR)...

2022-04-06 - BioCopy Looks Towards Diagnostics With New Platform, Planned ...

Carterra's LSA platform and Nicoya's Alto both use SPR to measure molecular interactions, which operates by principles similar to SCORE. In the...

2020-12-14 - PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization

Carterra LSA Instrument We are thrilled to have PerkinElmer as an investor and look forward to working together to advance our shared visions to improve drug discovery and life science research. SALT LAKE CITY (PRWEB) December 14, 2020 Carterra, Inc., the world leader in label-free high throug ...

2020-12-01 - Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairman of the Board of Directors

Carterra LSA Instrument I look forward to working alongside my fellow board members and company leadership to bring the world’s highest throughput, lowest sample consumption and most multiplexed label-free biosensor platform to every corner of the globe. SALT LAKE CITY (PRWEB) December 01, 2020 ...

2019-09-08 - Rapid European adoption of Carterra’s LSA platform fuels expansion

Carterra® Inc., the world leader in high-throughput antibody screening and characterization, announced today that they have opened a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.5M102-1%N/A
#2
$33.7M102-4%N/A
#3
$25.6M10220%N/A
#4
$21.4M1027%N/A
#5
$21.4M1021%N/A

Carterra Funding

DateAmountRoundLead InvestorsReference
2014-07-02$2.0MUndisclosedBioFire DiagnosticsArticle
2016-08-22$10.3MUndisclosedArticle
2018-01-18$10.0MUndisclosedTelegraph Hill PartnersArticle